Dear Seed Investor, The hits just keep on coming for Choom™ (CSE: CHOO; OTCQB: CHOOF) as they announce the closing of their $10.1 Million placement, with Aurora Cannabis as the cornerstone investor at $7 Million. Read the full release below: Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging fully-integrated cannabis company, is pleased to... Read more
Dear Seed Investor, What a week for our #1 Stock Pick Choom™ (CSE: CHOO; OTCQB: CHOOF) as they announce the closing of its acquisition of Specialty Medijuana Products. This follows the announcement earlier this week of a $10 Million placement, with $7 Million coming from Aurora Cannabis, leading to record... Read more
Marijuana stocks haven’t had an easy run of it in 2018. A bit of a correction was inevitable after such a strong 2017. However, a small group of marijuana stocks have bucked the downtrend and are multiplying investors money many times over in as little as a few weeks. Some of the... Read more
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it intends to complete a $7 million investment in Choom Holdings Inc. (CSE:CHOO) (OTCQB: CHOOF), whereby Aurora will receive 9,859,155 common shares from Choom’s treasury, priced at $0.71 per share, representing an 8% ownership interest. Choom currently operates two late... Read more
As The Seed Investor readers know, we’ve been on the “choomwagon” for a while now, even picking them as our #1 Marijuana Stock for 2018. And today, the second biggest Cannabis Company in Canada just got on board. Aurora Cannabis has made a massive, $7,000,000 investment in Choom! What makes a... Read more
InMed Pharmaceuticals Inc. (TSX:IN) is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase, as underwriter, 14,444,560 units of the Company, on a “bought deal” basis pursuant to the filing of a shelf prospectus... Read more
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to provide the following updates on its medical cannabis program and to re-affirm its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it. HISTORIC CLINICAL TRIAL MILESTONES Marking a major milestone for medical... Read more
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Anandia Laboratories Inc. announced today that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately $115 million on... Read more
On June 7, 2018, The Cannabis Bill passed the 3rd reading in the Canadian Senate and will now be kicked back to the House of Commons. According to the CBC, house members will debate the Senate’s amendments which include a public registry of cannabis industry investors (to dissuade organized crime) and a... Read more
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed the acquisition of 100% of the issued and outstanding shares of 8423695 Canada Inc. operating as Canveda, as previously announced on April 17, 2018. Canveda is a Licensed Producer under Health Canada’s Access to Cannabis for... Read more